Everest Medicines Ltd - Aug 5, 2025 SCHEDULE 13D Report for I-MAB Ordinary shares, par value US$0.0001 per share (IMAB)

Filing Manager: Everest Medicines Ltd
Reporting Manager: Everest Medicines Limited
Security: I-MAB Ordinary shares, par value US$0.0001 per share
Symbol: IMAB
Shares outstanding: 264M shares
Disclosed Ownership: 42.5M shares
Ownership: 16.1%
Form type: SCHEDULE 13D
Date filed: 8/5/2025, 04:00 PM
Date of event: Aug 5, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Everest Medicines Limited	16.1%	42.5M	42.5M	0	/s/ Ian Ying WOO	Ian Ying WOO, CFO&President	0001783937